12
Role of cytokines and lymphocytes on the efficacy of Posaconazole and Benznidazole in treatment of experimental acute Trypanosoma cruzi infection Alvaro José Romanha Centro de Pesquisa René Rachou – FIOCRUZ - MG Rio de Janeiro, July 2009.

Role of cytokines and lymphocytes on the efficacy of Posaconazole and Benznidazole in treatment of experimental acute Trypanosoma cruzi infection Alvaro

Embed Size (px)

Citation preview

Page 1: Role of cytokines and lymphocytes on the efficacy of Posaconazole and Benznidazole in treatment of experimental acute Trypanosoma cruzi infection Alvaro

Role of cytokines and lymphocytes on the efficacy of

Posaconazole and Benznidazole in treatment of

experimental acute Trypanosoma cruzi infection

Alvaro José Romanha

Centro de Pesquisa René Rachou – FIOCRUZ - MG

Rio de Janeiro, July 2009.

Page 2: Role of cytokines and lymphocytes on the efficacy of Posaconazole and Benznidazole in treatment of experimental acute Trypanosoma cruzi infection Alvaro

WT

IFN- KO

IL-12 KO

Page 3: Role of cytokines and lymphocytes on the efficacy of Posaconazole and Benznidazole in treatment of experimental acute Trypanosoma cruzi infection Alvaro

WT

IFN- KO

IL-12 KO

Page 4: Role of cytokines and lymphocytes on the efficacy of Posaconazole and Benznidazole in treatment of experimental acute Trypanosoma cruzi infection Alvaro

Mortality, survival and cure of WT, IFN-γ-KO and IL-12-KO mice infected with T.cruzi Y strain and treated with posaconazole and benznidazole

Treatment

Page 5: Role of cytokines and lymphocytes on the efficacy of Posaconazole and Benznidazole in treatment of experimental acute Trypanosoma cruzi infection Alvaro

Mortality, survival and cure of WT, IFN-γ-KO and IL-12-KO mice infected with T.cruzi Y strain and treated with posaconazole and benznidazole

Page 6: Role of cytokines and lymphocytes on the efficacy of Posaconazole and Benznidazole in treatment of experimental acute Trypanosoma cruzi infection Alvaro

Mortality, survival and cure of WT, IFN-γ-KO and IL-12-KO mice infected with T.cruzi Y strain and treated with posaconazole and benznidazole

Page 7: Role of cytokines and lymphocytes on the efficacy of Posaconazole and Benznidazole in treatment of experimental acute Trypanosoma cruzi infection Alvaro

Conclusion:

Our results demonstrate that either IFN-γ or IL-12 deficiency reduces

the efficacy of POS or BZ in the acute murine infection with T.cruzi but

also indicate that the anti-T.cruzi activity of POS is much less

dependent on the activity of IFN-γ than that of BZ.

Page 8: Role of cytokines and lymphocytes on the efficacy of Posaconazole and Benznidazole in treatment of experimental acute Trypanosoma cruzi infection Alvaro

WT

LTCD4+ KO

LTCD8+ KO

LB KO

Page 9: Role of cytokines and lymphocytes on the efficacy of Posaconazole and Benznidazole in treatment of experimental acute Trypanosoma cruzi infection Alvaro

WT

LTCD4+ KO

LTCD8+ KO

LB KO

Page 10: Role of cytokines and lymphocytes on the efficacy of Posaconazole and Benznidazole in treatment of experimental acute Trypanosoma cruzi infection Alvaro

Survival and cure of WT and CD4+ T-lymphocyte, CD8+ T-lymphocyte, and B-lymphocyte-KO mice infected with the Y strain of T.cruzi and treated with POS or BZ

Page 11: Role of cytokines and lymphocytes on the efficacy of Posaconazole and Benznidazole in treatment of experimental acute Trypanosoma cruzi infection Alvaro

Conclusion:

The absence of different lymphocytes’ activities has distinct effects

on the efficacy of POS and BZ in the acute murine infection with

T.cruzi, probably reflecting different parasite stages preferentially

targeted by the two drugs and distinct cooperation patterns with the

host immune system.

Page 12: Role of cytokines and lymphocytes on the efficacy of Posaconazole and Benznidazole in treatment of experimental acute Trypanosoma cruzi infection Alvaro

Collaborators:

Marcela L. Ferraz e Rosana O. AlvesLaboratório de Parasitologia Celular e Molecular, Centro de Pesquisa René Rachou,

FIOCRUZ-MG;

Ricardo T. GazzinelliLaboratório de Imunopatologia, Centro de Pesquisa René Rachou, FIOCRUZ-MG e

Departamento de Bioquímica e Imunologia, ICB-UFMG;

Julio A. UrbinaLaboratório de Química Biológica, Centro de Biofísica y Bioquímica, Instituto Venezolano de

Investigaciones Científicas, Venezuela